Why and how to use insulin therapy earlier in the management of type 2 diabetes

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Most patients with type 2 diabetes are inadequately controlled on their current therapy. Suboptimal glycemic control can have devastating consequences, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease that may ultimately lead to mortality. Most patients eventually need insulin therapy, and initiating insulin earlier in the course of type 2 diabetes may lead to optimal glycemic control and prevent or delay diabetes-related complications. Although insulin therapy is the most effective method of managing hyperglycemia, it is often delayed owing to concerns about the complexity and inconvenience of treatment regimens; fear of injections, hypoglycemia or weight gain; and the time required to learn how to effectively manage insulin therapy. The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals.

Original languageEnglish (US)
Pages (from-to)164-174
Number of pages11
JournalSouthern Medical Journal
Volume100
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Therapeutics
Biphasic Insulins
Diabetes Complications
Hypoglycemia
Hyperglycemia
Weight Gain
Fear
Cardiovascular Diseases
Injections
Mortality

Keywords

  • Analogs
  • Hypoglycemia
  • Insulin
  • Type 2 diabetes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Why and how to use insulin therapy earlier in the management of type 2 diabetes. / Meneghini, Luigi.

In: Southern Medical Journal, Vol. 100, No. 2, 02.2007, p. 164-174.

Research output: Contribution to journalArticle

@article{98f90f0b5a55400f8812cfb662d00010,
title = "Why and how to use insulin therapy earlier in the management of type 2 diabetes",
abstract = "Most patients with type 2 diabetes are inadequately controlled on their current therapy. Suboptimal glycemic control can have devastating consequences, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease that may ultimately lead to mortality. Most patients eventually need insulin therapy, and initiating insulin earlier in the course of type 2 diabetes may lead to optimal glycemic control and prevent or delay diabetes-related complications. Although insulin therapy is the most effective method of managing hyperglycemia, it is often delayed owing to concerns about the complexity and inconvenience of treatment regimens; fear of injections, hypoglycemia or weight gain; and the time required to learn how to effectively manage insulin therapy. The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals.",
keywords = "Analogs, Hypoglycemia, Insulin, Type 2 diabetes",
author = "Luigi Meneghini",
year = "2007",
month = "2",
doi = "10.1097/SMJ.0b013e31802ed2ea",
language = "English (US)",
volume = "100",
pages = "164--174",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Why and how to use insulin therapy earlier in the management of type 2 diabetes

AU - Meneghini, Luigi

PY - 2007/2

Y1 - 2007/2

N2 - Most patients with type 2 diabetes are inadequately controlled on their current therapy. Suboptimal glycemic control can have devastating consequences, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease that may ultimately lead to mortality. Most patients eventually need insulin therapy, and initiating insulin earlier in the course of type 2 diabetes may lead to optimal glycemic control and prevent or delay diabetes-related complications. Although insulin therapy is the most effective method of managing hyperglycemia, it is often delayed owing to concerns about the complexity and inconvenience of treatment regimens; fear of injections, hypoglycemia or weight gain; and the time required to learn how to effectively manage insulin therapy. The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals.

AB - Most patients with type 2 diabetes are inadequately controlled on their current therapy. Suboptimal glycemic control can have devastating consequences, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease that may ultimately lead to mortality. Most patients eventually need insulin therapy, and initiating insulin earlier in the course of type 2 diabetes may lead to optimal glycemic control and prevent or delay diabetes-related complications. Although insulin therapy is the most effective method of managing hyperglycemia, it is often delayed owing to concerns about the complexity and inconvenience of treatment regimens; fear of injections, hypoglycemia or weight gain; and the time required to learn how to effectively manage insulin therapy. The development of insulin analogs, biphasic insulin analogs, and more convenient insulin delivery systems may make insulin therapy more manageable and help more patients achieve their treatment goals.

KW - Analogs

KW - Hypoglycemia

KW - Insulin

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=33846804204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846804204&partnerID=8YFLogxK

U2 - 10.1097/SMJ.0b013e31802ed2ea

DO - 10.1097/SMJ.0b013e31802ed2ea

M3 - Article

C2 - 17330687

AN - SCOPUS:33846804204

VL - 100

SP - 164

EP - 174

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 2

ER -